scispace - formally typeset
P

Pierre L. Beaulieu

Researcher at Boehringer Ingelheim

Publications -  135
Citations -  4781

Pierre L. Beaulieu is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Hepatitis C virus & Polymerase. The author has an hindex of 36, co-authored 133 publications receiving 4640 citations.

Papers
More filters
Patent

Condensed triclyclic compounds as inhibitors of hiv replication

TL;DR: In this article, the authors proposed an inbitor of HIV replication using a combination of formula (I) and pharmaceutical compositions thereof, where A 1 A 2 and A 3 are each independently selected from the group consisting of N and CR 3, wherein R 1 is an optionally substituted heterocyclyl or an optionally substituting -(C 1-6 )alkyl-heterocycyll, R 2 is an alternatively substituted aryl or a optionally subsisted heteroaryl, R 4 is a optionally substituted ayl, and R 5 is an an
Journal ArticleDOI

Synthesis of ketones by cyclization of cyano and acetylenic radicals: use of .delta.-hydroxy nitriles and .delta.- or .epsilon.-hydroxy acetylenes

TL;DR: Le radical intermediaire genere par desoxygenation d'alcools peut operer une cyclisation intramoleculaire quand des liaisons C≡C et c≡N sont presentes.
Journal ArticleDOI

Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements.

TL;DR: The discovery of potent (2-3 microM), hydrolytically stable dipeptide derivatives, bearing only two charges at physiological pH, represents a significant step toward the discovery of compounds with cellular activity and the development of novel therapeutics for conditions associated with undesired T-cell proliferation.
Journal ArticleDOI

Large scale preparation of (2S,3S)-N-Boc-3-amino-1,2-epoxy-4-phenylbutane: A key building block for HIV-protease inhibitors

TL;DR: In this article, the synthesis of (2S,3S)-N-Boc-3amino-1,2-epoxy-4-phenylbutane is described.